Financial Snapshot

Revenue
$1.819M
TTM
Gross Margin
84.77%
TTM
Net Earnings
-$7.191M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
4.25%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$9.344M
Q3 2024
Cash
Q3 2024
P/E
-0.2504
Nov 29, 2024 EST
Free Cash Flow
-$512.1K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2012 2011 2010 2009 2008 2007 2006 2002 2001 2000 1999 1998 1997
Revenue $1.498M $1.219M $827.3K $1.090M $1.140M $0.00 $0.00 $2.000K $6.040K $0.00 $0.00 $0.00 $8.230M $7.650M $6.560M $4.720M $1.800M $540.0K
YoY Change 22.88% 47.34% -24.1% -4.39% -100.0% -66.89% 7.58% 16.62% 38.98% 162.22% 233.33%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2012 2011 2010 2009 2008 2007 2006 2002 2001 2000 1999 1998 1997
Revenue $1.498M $1.219M $827.3K $1.090M $1.140M $0.00 $0.00 $2.000K $6.040K $0.00 $0.00 $0.00 $8.230M $7.650M $6.560M $4.720M $1.800M $540.0K
Cost Of Revenue $284.4K $262.7K $108.7K $210.0K $290.0K $0.00 $0.00 $0.00 $56.71K
Gross Profit $1.213M $956.2K $718.6K $880.0K $850.0K $0.00 $0.00 $2.000K -$50.67K
Gross Profit Margin 81.01% 78.45% 86.86% 80.73% 74.56% 100.0% -838.91%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2012 2011 2010 2009 2008 2007 2006 2002 2001 2000 1999 1998 1997
Selling, General & Admin $9.785M $9.022M $1.260M $1.160M $50.00K $130.0K $167.9K $230.3K $0.00 $0.00 $0.00 $8.910M $9.020M $8.390M $7.020M $2.110M $610.0K
YoY Change 8.46% 8.62% -61.54% -22.57% -27.1% -1.22% 7.51% 19.52% 232.7% 245.9%
% of Gross Profit 806.46% 943.57% 143.18% 136.47% 8395.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.24K $349.9K $313.8K $0.00 $0.00 $0.00 $4.610K $0.00 $110.0K $340.0K $340.0K $300.0K $110.0K $20.00K
YoY Change -95.07% 11.48% -100.0% -67.65% 0.0% 13.33% 172.73% 450.0%
% of Gross Profit 1.42% 36.59% 43.67% 0.0% 230.5%
Operating Expenses $9.786M $9.022M $8.458M $1.260M $1.160M $50.00K $130.0K $172.5K $234.7K $10.00K $0.00 $0.00 $9.020M $9.360M $8.650M $8.710M $2.180M $610.0K
YoY Change 8.47% 6.67% 571.3% 8.62% -61.54% -24.64% -26.5% 2247.1% -3.63% 8.21% -0.69% 299.54% 257.38%
Operating Profit -$8.573M -$8.066M -$7.740M -$380.0K -$310.0K -$50.00K -$130.0K -$170.5K -$285.4K
YoY Change 6.28% 4.22% 1936.78% 22.58% -61.54% -23.76% -40.25%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2012 2011 2010 2009 2008 2007 2006 2002 2001 2000 1999 1998 1997
Interest Expense $614.0K $324.4K $157.3K -$10.00K -$10.00K $0.00 $0.00 $0.00 -$400.0K -$160.0K -$90.00K -$520.0K $0.00 -$10.00K
YoY Change 89.29% 106.18% -1673.3% 0.0% 150.0% 77.78% -82.69% -100.0%
% of Operating Profit
Other Income/Expense, Net -$2.529M -$1.985M -$678.9K $0.00 -$20.00K $0.00
YoY Change 27.4% 192.33% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2012 2011 2010 2009 2008 2007 2006 2002 2001 2000 1999 1998 1997
Pretax Income -$11.10M -$10.05M -$8.419M -$260.0K -$330.0K -$50.00K -$130.0K -$170.5K -$285.4K -$10.00K $0.00 $0.00 -$1.190M -$1.860M -$2.180M -$7.760M -$400.0K -$70.00K
YoY Change 10.45% 19.39% 3137.96% -21.21% -61.54% -23.76% -40.25% 2753.8% -36.02% -14.68% -71.91% 1840.0% 471.43%
Income Tax $2.033K $674.3K -$666.6K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.10M -$10.73M -$7.752M -$130.0K -$160.0K -$50.00K -$130.0K -$170.5K -$285.4K -$10.00K $0.00 $0.00 -$1.190M -$870.0K -$2.180M -$7.760M -$400.0K -$70.00K
YoY Change 3.53% 38.35% 5863.15% -18.75% -61.54% -23.76% -40.25% 2753.8% 36.78% -60.09% -71.91% 1840.0% 471.43%
Net Earnings / Revenue -741.33% -879.92% -937.07% -11.93% -14.04% -8525.5% -4724.83% -14.46% -11.37% -33.23% -164.41% -22.22% -12.96%
Basic Earnings Per Share -$0.28 -$0.46
Diluted Earnings Per Share -$0.28 -$0.28 -$0.46 -$5.013K -$6.170K -$59.52K -$1.625M -$289.0M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2012 2011 2010 2009 2008 2007 2006 2002 2001 2000 1999 1998 1997
Cash & Short-Term Investments $1.000M $1.050M $10.00K $0.00 $0.00 $30.00 $0.00 $0.00 $0.00 $260.0K $420.0K $460.0K $400.0K $200.0K $90.00K
YoY Change 10400.0% -100.0% -38.1% -8.7% 15.0% 100.0% 122.22%
Cash & Equivalents $751.0K $1.040M $0.00 $0.00 $0.00 $260.0K $420.0K $460.0K $400.0K $200.0K $90.00K
Short-Term Investments $249.1K $10.00K $10.00K
Other Short-Term Assets $230.0K $230.0K $228.6K $228.6K $14.40M $4.220M $4.330M $2.720M $140.0K $0.00
YoY Change 0.0% 0.62% 0.0% 241.23% -2.54% 59.19% 1842.86%
Inventory
Prepaid Expenses
Receivables $525.1K $590.0K $720.0K $520.0K $150.0K $290.0K $220.0K $50.00K $10.00K
Other Receivables $200.7K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $1.726M $1.640M $730.0K $230.0K $230.0K $228.6K $228.6K $0.00 $0.00 $15.17M $4.790M $5.080M $3.330M $390.0K $90.00K
YoY Change 124.66% 0.0% 0.61% 0.01% 216.7% -5.71% 52.55% 753.85% 333.33%
Property, Plant & Equipment $395.8K $0.00 $0.00 $210.00 $3.390K $260.0K $360.0K $370.0K $440.0K $260.0K $60.00K
YoY Change -100.0% -93.81% -27.78% -2.7% -15.91% 69.23% 333.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00 $1.000K $1.000K $70.00K $0.00 $0.00 $110.0K $70.00K $70.00K $560.0K $70.00K $30.00K
YoY Change -100.0% 0.0% -98.57% 57.14% 0.0% -87.5% 700.0% 133.33%
Total Long-Term Assets $1.214M $0.00 $0.00 $100.0K $100.0K $101.2K $104.4K $4.840M $4.840M $5.200M $5.520M $5.530M $6.470M $3.920M $90.00K
YoY Change 0.0% -1.2% -3.05% 0.0% -5.8% -0.18% -14.53% 65.05% 4255.56%
Total Assets $2.940M $1.640M $730.0K $330.0K $330.0K $329.8K $333.0K $4.910M $4.840M $4.840M $20.37M $10.31M $10.61M $9.800M $4.310M $180.0K
YoY Change
Accounts Payable $738.4K $930.0K $760.0K $110.0K $100.0K $85.00K $70.09K $490.0K $590.0K $650.0K $400.0K $170.0K $20.00K
YoY Change 22.37% 10.0% 17.65% 21.27% -16.95% -9.23% 62.5% 135.29% 750.0%
Accrued Expenses $648.9K $120.0K $140.0K $78.32K $39.90K $1.890M $1.470M $1.030M $420.0K $50.00K $20.00K
YoY Change -14.29% 78.75% 96.29% 28.57% 42.72% 145.24% 740.0% 150.0%
Deferred Revenue
YoY Change
Short-Term Debt $140.3K $240.0K $230.0K $0.00 $0.00 $0.00 $0.00 $0.00 $13.21M $3.390M $4.110M $3.010M $0.00 $0.00
YoY Change 4.35% 289.68% -17.52% 36.54%
Long-Term Debt Due $5.300K $0.00 $0.00 $10.00K $0.00 $40.00K $30.00K $10.00K $10.00K
YoY Change -100.0% 33.33% 200.0% 0.0%
Total Short-Term Liabilities $1.533M $1.170M $1.000M $230.0K $260.0K $185.0K $110.0K $10.00K $20.00K $10.00K $16.65M $6.350M $5.830M $3.870M $230.0K $50.00K
YoY Change 17.0% -11.54% 40.58% 68.15% 999.9% -50.0% 100.0% 162.2% 8.92% 50.65% 1582.61% 360.0%
Long-Term Debt $2.767M $20.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $0.00 $1.170M $1.810M $10.00K $20.00K
YoY Change -100.0% -35.36% 18000.0% -50.0%
Other Long-Term Liabilities $283.1K $60.00K $60.00K $55.30K $32.40K
YoY Change 0.0% 8.5% 70.68%
Total Long-Term Liabilities $3.050M $20.00K $0.00 $60.00K $60.00K $55.30K $32.40K $0.00 $0.00 $0.00 $10.00K $0.00 $1.170M $1.810M $10.00K $20.00K
YoY Change 0.0% 8.5% 70.68% -100.0% -35.36% 18000.0% -50.0%
Total Liabilities $4.581M $900.0K $840.0K $290.0K $320.0K $240.3K $142.4K $10.00K $20.00K $10.00K $16.65M $6.350M $7.000M $5.680M $240.0K $70.00K
YoY Change 7.14% -9.38% 33.19% 68.73% 1323.9% -50.0% 100.0% 162.2% -9.29% 23.24% 2266.67% 242.86%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2012 2011 2010 2009 2008 2007 2006 2002 2001 2000 1999 1998 1997
Basic Shares Outstanding 39.97M shares 38.79M shares 16.99M shares
Diluted Shares Outstanding 39.97M shares 38.79M shares 16.99M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.8007 Million

About Optimus Healthcare Services, Inc.

Optimus Healthcare Services, Inc. is focused on creating a network of innovative healthcare companies that advance clinical research, disease management, and improve physician or patient interactions. The company is headquartered in Westbury, New York and currently employs 12 full-time employees. CRA provides services to a team of dedicated oncologists across the Tri-State area that are united by a shared commitment to conduct clinical research. CRA provides independent, community-based oncology practices and hospitals in diverse communities with the necessary infrastructure and support to enroll their patients in clinical trials without the patients having to leave their physicians' offices, hospitals or their local communities. CRA's focus is on oncology practices, as well as hospitals in diverse communities. CRA contracts with pharmaceutical companies and Contract Research Organizations (CRO) to conduct clinical trials (Phases I-IV) for investigational new drugs, biologics and medical devices. CRA's customers consist primarily of large and mid-sized pharmaceutical and biotech companies.

Industry: Services-Commercial Physical & Biological Research Peers: